Cabazitaxel is an antineoplastic drug used in chemotherapy, commonly sold under the brand name Jevtana. It is classified as a “taxane derivative”, which means it is a drug that stops mitosis. [1] [2] It is approved for castrate-resistant metastatic prostate cancer (CRMP) treatment in patients who are previously treated with docetaxel (another type of taxane)....Continue Reading